Page last updated: 2024-08-17

prednisone and caffeine

prednisone has been researched along with caffeine in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19907 (24.14)18.7374
1990's1 (3.45)18.2507
2000's14 (48.28)29.6817
2010's6 (20.69)24.3611
2020's1 (3.45)2.80

Authors

AuthorsStudies
Duffy, EM; Jorgensen, WL1
Topliss, JG; Yoshida, F1
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Jolivette, LJ; Ward, KW1
Carrupt, PA; Martel, S; Ottaviani, G1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Balliano, TL; Barbosa, G; Carvalho, VF; da Silva, BA; de Souza, ET; Lima, LM; Martins, IRR; Martins, MA; Medeiros, MM; Moraes Junior, MO; Nunes, IKDC; Silva, PMR; Silva, SWD1
Rölke, HW1
Levy, G1
Goenechea, S1
Ludewig, H; Ludewig, W; Poppe, G; Poppe, W1
Baba, H; Fujihara, A; Inoue, K; Isayama, T; Kanamiya, T; Maehara, Y; Ogata, K; Yoh, S; Yoshitake, K1
THURAU, H1
JAKLITSCH, H1
MIRECKI, GB1
Caldarola, G; Cozzani, E; Parodi, A; Pellicano, R1

Reviews

1 review(s) available for prednisone and caffeine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

28 other study(ies) available for prednisone and caffeine

ArticleYear
Prediction of drug solubility from Monte Carlo simulations.
    Bioorganic & medicinal chemistry letters, 2000, Jun-05, Volume: 10, Issue:11

    Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility

2000
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
ElogPoct: a tool for lipophilicity determination in drug discovery.
    Journal of medicinal chemistry, 2000, Jul-27, Volume: 43, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents

2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
    Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water

2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
    Journal of medicinal chemistry, 2007, Feb-22, Volume: 50, Issue:4

    Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
    European journal of medicinal chemistry, 2020, Oct-15, Volume: 204

    Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; Humans; Hydrazones; Hypersensitivity; Lung; Male; Mice

2020
[On the treatment of inflammatory and degenerative diseases of the musculosketetal system with Vertebran].
    Deutsches medizinisches Journal, 1968, Dec-05, Volume: 19, Issue:23

    Topics: Atropine; Bone Diseases; Caffeine; Ergoloid Mesylates; Humans; Joint Diseases; Muscular Diseases; Pain; Prednisone; Pyrazoles; Strychnine

1968
Effect of complex formation on drug absorption.
    Acta pharmacologica et toxicologica, 1971, Volume: 29 Suppl 3

    Topics: Amides; Animals; Antipyrine; Body Weight; Caffeine; Cyprinidae; Drug Interactions; Hydrogen-Ion Concentration; Intestinal Absorption; Kinetics; Prednisone; Propionates; Rats; Salicylamides; Secobarbital; Solubility; Surface-Active Agents; Time Factors

1971
[IR demonstration of caffeine in the brain after Vertebran poisoning].
    Deutsche Zeitschrift fur die gesamte gerichtliche Medizin, 1967, Volume: 61, Issue:3

    Topics: Alkaloids; Atropine; Brain Chemistry; Caffeine; Chromatography, Thin Layer; Humans; Infant; Infrared Rays; Prednisone; Pyrazoles; Spectrum Analysis; Strychnine

1967
[The shy-drager syndrom, a disease of second half of life (author's transl)].
    Zeitschrift fur Alternsforschung, 1980, Volume: 35, Issue:3

    Topics: Aged; Autonomic Nervous System Diseases; Bandages; Caffeine; Dexamethasone; Erectile Dysfunction; Facial Paralysis; Female; Humans; Hypohidrosis; Hypotension, Orthostatic; Male; Middle Aged; Muscle Rigidity; Prednisone; Shy-Drager Syndrome

1980
[Intra-arterial combination chemotherapy using both regimen selected by chemosensitivity test and caffeine to increase effect for osteosarcoma in extremity].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Extremities; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Osteosarcoma; Prednisone; Succinate Dehydrogenase

1994
[Experiences in the treatment of bronchial asthma with Afran].
    Medizinische Klinik, 1962, Jan-26, Volume: 57

    Topics: Aminopyrine; Asthma; Caffeine; Prednisone

1962
[THOUGHTS ON THE CONSERVATIVE THERAPY OF VERTEBRAL SYNDROMES].
    Wiener medizinische Wochenschrift (1946), 1964, Apr-25, Volume: 114

    Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Atropine; Caffeine; Ergot Alkaloids; Humans; Intervertebral Disc Displacement; Osteochondritis; Periarthritis; Prednisolone; Prednisone; Procaine; Spinal Diseases; Spondylitis; Strychnine; Syndrome

1964
[FURTHER EXPERIENCES WITH VERTEBRAN IN ORTHOPEDIC PRACTICE].
    Munchener medizinische Wochenschrift (1950), 1965, Feb-26, Volume: 107

    Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Atropine; Back Pain; Brachial Plexus Neuritis; Caffeine; Drug Therapy; Ergotamine; Humans; Hydrocortisone; Joint Diseases; Osteochondritis; Polymyalgia Rheumatica; Prednisolone; Prednisone; Procaine; Reflex Sympathetic Dystrophy; Spinal Osteophytosis; Spondylitis; Spondylitis, Ankylosing; Strychnine

1965
A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic.
    Clinical therapeutics, 2009, Volume: 31, Issue:9

    Topics: Aminopyrine; Barbiturates; Caffeine; Drug Combinations; Female; Glucocorticoids; Humans; Immunoglobulin A; Middle Aged; Prednisone; Skin Diseases, Vesiculobullous; Sunlight; Ultraviolet Rays

2009